Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Intensive Care Medicine|September 13, 2005
The effect of molecular adsorbent recirculating system on pathophysiological parameters in patients with acute liver failureWai Kwan Lai, Geoff Haydon, David Mutimer, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|February 17, 2006
Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutantsWan-Xing Zhang, Vincent Lai, David Mutimer, et al.
Journal of Gastroenterology and Hepatology|April 20, 2005
Association of fulminant non-A non-B hepatitis with homozygosity for HLA A1-B8-DR3Paul Gow, Mark Hathaway, Bridget Gunson, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 29, 2007
Tacrolimus and cyclosporin doses and blood levels in hepatitis C and alcoholic liver disease patients after liver transplantationYe H Oo, Tracey Dudley, Peter Nightingale, et al.
Journal of Medical Virology|September 26, 2024
Determinants of HBeAg loss during follow-up of a multiethnic pediatric cohortDavid Mutimer, Sowsan F Atabani, Maxine Brown, et al.
Leukemia Research|March 7, 2006
Adult T-cell leukemia presenting with acute liver failureNicholas Powell, Ferry Rusli, Stefan G Hubscher, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 10, 2002
Modeling costs and cost-effectiveness of different CMV management strategies in liver transplant recipients as a support for current and future decision makingLieven Annemans, Karen Moeremans, David Mutimer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 18, 2006
Results of combination treatment with pegylated interferon and ribavirin in cirrhotic patients with hepatitis C infectionBarbara Höroldt, Geoffrey Haydon, Katrina O'Donnell, et al.
International Journal of Clinical Pharmacy|February 27, 2020
Impact of HIV and chronic kidney disease comorbidities on hepatitis C treatment choices, drug-drug interactions and hepatitis C cureSalamat Ali, Tofeeq Ur-Rehman, Eleri Lougher, et al.
Public Health in Practice (Oxford, England)|November 1, 2021
An experience using historical hepatitis C data to Re-Engage: Possibilities and pitfalls during the COVID-19 pandemicWilliam Osborne, Noorann Sheikh, Gemma Botterill, et al.
Pageof 5